185 related articles for article (PubMed ID: 33836782)
1. Impact of newborn screening for cystic fibrosis on clinical outcomes of pediatric patients: 10 years' experience in Lodz Voivodship.
Olszowiec-Chlebna M; Mospinek E; Jerzynska J
Ital J Pediatr; 2021 Apr; 47(1):87. PubMed ID: 33836782
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
Ren CL; Desai H; Platt M; Dixon M
Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis newborn screening does not delay the identification of cystic fibrosis in children with negative results.
Maclean JE; Solomon M; Corey M; Selvadurai H
J Cyst Fibros; 2011 Sep; 10(5):333-7. PubMed ID: 21536503
[TBL] [Abstract][Full Text] [Related]
5. Complications associated with symptomatic diagnosis in infants with cystic fibrosis.
Accurso FJ; Sontag MK; Wagener JS
J Pediatr; 2005 Sep; 147(3 Suppl):S37-41. PubMed ID: 16202780
[TBL] [Abstract][Full Text] [Related]
6. Benefits of newborn screening for cystic fibrosis in Shreveport, Louisiana, Cystic Fibrosis Center.
Venkata JA; Jones KL
J La State Med Soc; 2011; 163(6):316-9. PubMed ID: 22324090
[TBL] [Abstract][Full Text] [Related]
7. Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatment.
Sims EJ; McCormick J; Mehta G; Mehta A;
J Pediatr; 2005 Sep; 147(3 Suppl):S42-6. PubMed ID: 16202781
[TBL] [Abstract][Full Text] [Related]
8. Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening.
Munck A; Bourmaud A; Bellon G; Picq P; Farrell PM;
Pediatr Pulmonol; 2020 Apr; 55(4):918-928. PubMed ID: 31916691
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis newborn screening: Five-year experience from a tertiary care center.
Nayir Buyuksahin H; Emiralioglu N; Ozsezen B; Ademhan Tural D; Sunman B; Guzelkas I; Tezel B; Dayangaç Erden D; Yalçın E; Dogru D; Ozcelik U; Kiper N
Pediatr Pulmonol; 2022 Feb; 57(2):403-410. PubMed ID: 34842364
[TBL] [Abstract][Full Text] [Related]
10. Differences in Outcomes between Early and Late Diagnosis of Cystic Fibrosis in the Newborn Screening Era.
Coffey MJ; Whitaker V; Gentin N; Junek R; Shalhoub C; Nightingale S; Hilton J; Wiley V; Wilcken B; Gaskin KJ; Ooi CY
J Pediatr; 2017 Feb; 181():137-145.e1. PubMed ID: 27837951
[TBL] [Abstract][Full Text] [Related]
11. The benefits of newborn screening for cystic fibrosis: The Canadian experience.
Mak DY; Sykes J; Stephenson AL; Lands LC
J Cyst Fibros; 2016 May; 15(3):302-8. PubMed ID: 27118577
[TBL] [Abstract][Full Text] [Related]
12. Neonatal screening programme for CF: Results from the Irish Comparative Outcomes Study (ICOS).
Fitzgerald C; Linnane B; George S; Ni Chroinin M; Mullane D; Herzig M; Greally P; Elnazir B; Healy F; Mc Nally P; Javadpour S; Cox D; Fitzpatrick P
Pediatr Pulmonol; 2020 Sep; 55(9):2323-2329. PubMed ID: 32470170
[TBL] [Abstract][Full Text] [Related]
13. Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa.
McKay KO; Cooper PJ; van Asperen PP
J Cyst Fibros; 2009 Dec; 8(6):400-4. PubMed ID: 19716353
[TBL] [Abstract][Full Text] [Related]
14. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!
Farrell PM; Lai HJ; Li Z; Kosorok MR; Laxova A; Green CG; Collins J; Hoffman G; Laessig R; Rock MJ; Splaingard ML
J Pediatr; 2005 Sep; 147(3 Suppl):S30-6. PubMed ID: 16202779
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening.
Hayes D; Farrell PM; Li Z; West SE
Pediatr Pulmonol; 2010 Jan; 45(1):55-61. PubMed ID: 20025049
[TBL] [Abstract][Full Text] [Related]
16. Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre.
Dijk FN; McKay K; Barzi F; Gaskin KJ; Fitzgerald DA
Arch Dis Child; 2011 Dec; 96(12):1118-23. PubMed ID: 21994242
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.
Ooi CY; Sutherland R; Castellani C; Keenan K; Boland M; Reisman J; Bjornson C; Chilvers MA; van Wylick R; Kent S; Price A; Mateos-Corral D; Hughes D; Solomon M; Zuberbuhler P; Brusky J; Durie PR; Ratjen F; Gonska T
BMC Pediatr; 2019 Oct; 19(1):369. PubMed ID: 31640630
[TBL] [Abstract][Full Text] [Related]
18. Real-world Associations of US Cystic Fibrosis Newborn Screening Programs With Nutritional and Pulmonary Outcomes.
Rosenfeld M; Ostrenga J; Cromwell EA; Magaret A; Szczesniak R; Fink A; Schechter MS; Faro A; Ren CL; Morgan W; Sanders DB
JAMA Pediatr; 2022 Oct; 176(10):990-999. PubMed ID: 35913705
[TBL] [Abstract][Full Text] [Related]
19. Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK CF registry-based study.
Schlüter DK; Southern KW; Dryden C; Diggle P; Taylor-Robinson D
Thorax; 2020 Feb; 75(2):123-131. PubMed ID: 31771956
[TBL] [Abstract][Full Text] [Related]
20. Sweat test practice in pediatric pulmonology after introduction of cystic fibrosis newborn screening.
Grimaldi C; Brémont F; Berlioz-Baudoin M; Brouard J; Corvol H; Couderc L; Lezmi G; Pin I; Petit I; Reix P; Remus N; Schweitzer C; Thumerelle C; Dubus JC
Eur J Pediatr; 2015 Dec; 174(12):1613-20. PubMed ID: 26074372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
